---
title: "IQVIA und Duke Clinical Research Institute starten strategische Zusammenarbeit für klinische Forschung"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/275462174.md"
datetime: "2026-02-10T13:01:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275462174.md)
  - [en](https://longbridge.com/en/news/275462174.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275462174.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/275462174.md) | [繁體中文](https://longbridge.com/zh-HK/news/275462174.md)


# IQVIA und Duke Clinical Research Institute starten strategische Zusammenarbeit für klinische Forschung

IQVIA Holdings Inc. und das Duke Clinical Research Institute (DCRI) haben eine strategische Zusammenarbeit angekündigt, um die klinische Forschung im Bereich Adipositas und verwandter kardiometabolischer Erkrankungen zu fördern. Durch die Verbindung von IQVIAs globaler Reichweite und operativer Exzellenz mit der wissenschaftlichen Expertise des DCRI sollen klinische Studien effizienter geplant und durchgeführt sowie innovative Therapien schneller zu den Patienten gebracht werden. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IQVIA Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260210139483) on February 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### 相关股票

- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-CN/quote/SBIO.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-CN/quote/FBT.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-CN/quote/PBE.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-CN/quote/BIB.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [IQVIA (IQV.US)](https://longbridge.com/zh-CN/quote/IQV.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-CN/quote/XBI.US.md)

## 相关资讯与研究

- [BUZZ-Caribou rises on FDA's regenerative medicine advanced therapy tag for blood cancer therapy](https://longbridge.com/zh-CN/news/281186075.md)
- [SeaStar Medical Highlights New Positive QUELIMMUNE Data In Pediatric AKI](https://longbridge.com/zh-CN/news/281121555.md)
- [Palisade Bio Shares Phase 1b PALI-2108 Data Showing Safety, PK and Early Crohn’s Efficacy Signals](https://longbridge.com/zh-CN/news/281229588.md)
- [Precigen Details Papzimeos Commercial Launch, Hub Growth and J-Code Catalyst at H.C. Wainwright Chat](https://longbridge.com/zh-CN/news/281233412.md)
- [09:00 ETCOCOLAB™ Named #1 Dentist-Recommended Woven Floss Brand](https://longbridge.com/zh-CN/news/281528403.md)